Pharma News

Ipsen acquires global rights to SIM0613, a preclinical LRRC15-targeting ADC from Simcere Zaiming. Learn about this $1.06B deal and the future of oncology therapeutics.

Explore the approval of ZURZUVAE in Canada. The first 14-day oral treatment for postpartum depression showing rapid results in 3 days. Learn more about CNS innovations.

Enhertu granted FDA Breakthrough status

Mondego Bio Announces Selection of a PTPN2 Inhibitor Clinical Candidate and Targets First-in-Human Trials in H1 2026

BioMarin snaps up Amicus Therapeutics for $4.8bn amid rare disease push

Cytokinetics receives FDA approval for MYQORZO tablets for oHCM

New drug may slow progression of ALS in small group of patients: Study

Alnylam plans $250m investment in Norton manufacturing facility, US

EC approves Incyte’s Minjuvi combo for follicular lymphoma

Many companies and businesses have viewed artificial intelligence (AI) as a tool for amplifying efficiency, such as automating simple tasks and making backend projects more efficient.

TSC Alliance Endowment Fund Invests in Aeovian Pharmaceuticals to Advance Development of an mTORC1 Selective Inhibitor for Tuberous Sclerosis Complex

Promising Target Improves Antitumor Response in Preclinical Models of Pancreatic Cancer